Catalyst Wire Dossier Catalyst Wire Dossier

Velpatasvir/sofosbuvir (generic)

Velpatasvir/sofosbuvir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Velpatasvir/sofosbuvir (generic), covering 2017-12-08 to 2017-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients [Phase 4]

See pricing